Compare DHX & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHX | LENZ |
|---|---|---|
| Founded | 1991 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.3M | 155.5M |
| IPO Year | 2007 | 2021 |
| Metric | DHX | LENZ |
|---|---|---|
| Price | $4.21 | $4.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $6.25 | ★ $44.00 |
| AVG Volume (30 Days) | 203.3K | ★ 817.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $127,826,000.00 | $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | $3.52 | $197.16 |
| P/E Ratio | $42.20 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.44 | $4.54 |
| 52 Week High | $4.50 | $50.19 |
| Indicator | DHX | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.74 | 36.98 |
| Support Level | $3.39 | N/A |
| Resistance Level | $4.18 | $6.18 |
| Average True Range (ATR) | 0.34 | 0.41 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 70.72 | 2.49 |
DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.